Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | KAND567 |
Synonyms | |
Therapy Description |
KAND567 is a small molecule inhibitor of CX3CR1, which inhibits DNA damage repair and enhances sensitivity to chemotherapeutic agents, potentially leading to decreased tumor cell viability (PMID: 33810010, NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
KAND567 | KAND-567|KAND 567|AZD8797|AZD-8797|AZD 8797 | KAND567 is a small molecule inhibitor of CX3CR1, which inhibits DNA damage repair and enhances sensitivity to chemotherapeutic agents, potentially leading to decreased tumor cell viability (PMID: 33810010, NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|